Related Experiment Video
Updated: Jan 19, 2026
MicroRNAs and the RISC
GOLGA7 rs11337, a Polymorphism at the MicroRNA Binding Site, Is Associated with Glioma Prognosis
Linghui Zhou1, Shanshan Dong2, Yujiao Deng1
1Department of Breast Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China; Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China.
Abstract:
MicroRNAs bind to the 3' untranslated regions of mRNAs, affecting translation, tumorigenesis, and apoptosis. This study evaluated the role of TYMS (rs1059394, C > T, and rs2847153, G > A), RYR3 (rs1044129, G > A), KIAA0423 (rs1053667, T > C), and GOLGA7 (rs11337, G > T) polymorphisms for assessment of glioma risk and prognosis among the Chinese Han population. Five single-nucleotide polymorphisms were assessed in 605 glioma patients and 1,300 controls. We found a significant correlation between rs1059394 and glioma susceptibility in the homozygote and dominant genetic models (TT versus CC, odds ratio [OR] = 0.71, 95% confidence interval [CI] = 0.52-0.97, p = 0.03; CT+TT versus CC, OR = 0.74, 95% CI = 0.55-0.99, p = 0.04). The results of the Kaplan-Meier and log rank tests revealed that the rs11337 GG genotype correlated with better overall survival of glioma patients (p = 0.017) than the GT genotype. Multivariate Cox regression analysis results also showed that the rs11337 GT genotype correlated with worse overall survival (p = 0.017, hazard ratio [HR] = 1.25, 95% CI = 1.04-1.5) than the GG genotype. These results suggest that GOLGA7 (rs11337) polymorphism may play a role in the prognosis of glioma patients and that TYMS (rs1059394) is associated with glioma risk.
Insights
This study links TYMS (rs1059394) gene variations to glioma risk and GOLGA7 (rs11337) variations to glioma patient survival in the Chinese Han population.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- MicroRNAs (miRNAs) regulate gene expression and are implicated in tumorigenesis.
- Genetic variations in miRNA-related genes can influence cancer susceptibility and outcomes.
- Glioma is a common primary brain tumor with significant mortality.
Purpose of the Study:
- To investigate the association between single-nucleotide polymorphisms (SNPs) in TYMS, RYR3, KIAA0423, and GOLGA7 genes and glioma risk.
- To evaluate the impact of these SNPs on the prognosis of glioma patients.
Main Methods:
- Case-control study involving 605 glioma patients and 1,300 controls from the Chinese Han population.
- Genotyping of five SNPs: TYMS (rs1059394, rs2847153), RYR3 (rs1044129), KIAA0423 (rs1053667), and GOLGA7 (rs11337).
- Statistical analyses including logistic regression, Kaplan-Meier, log rank tests, and Cox regression were employed.
Main Results:
- The TYMS rs1059394 polymorphism was significantly associated with increased glioma susceptibility in homozygote and dominant models.
- The GOLGA7 rs11337 GG genotype was correlated with better overall survival in glioma patients compared to the GT genotype.
- Cox regression analysis indicated that the GOLGA7 rs11337 GT genotype was a predictor of worse overall survival.
Conclusions:
- The TYMS rs1059394 polymorphism may contribute to glioma risk in the studied population.
- The GOLGA7 rs11337 polymorphism is a potential prognostic marker for glioma patients, influencing overall survival.
Related Concept Videos
MicroRNAs
MicroRNAs
07:37Circulating MicroRNA Quantification Using DNA-binding Dye Chemistry and Droplet Digital PCR
11:51Potato Virus X-Based microRNA Silencing (VbMS) In Potato.
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
07:23Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

